Trademark and Unfair Competition Law Developments

Featured

Ted Davis, Kilpatrick Townsend & Stockton LLP

Join us on June 21, 2022 for our next webinar. We anticipate 1.00 General CLE credit in Ohio for this event. 

Our presenter will be Ted Davis from Kilpatrick Townsend & Stockton LLP. Mr. Davis will present on Trademark and Unfair Competition Law Developments. 

Speaker Ted Davis will discuss developments in trademark and unfair competition law over the trailing twelve months, including: 

  • The effective date of most (but not all) of the Trademark Modernization Act;
  • Constitutional challenges to the appointment of the TTAB’s administrative law judges;
  • Significant opinions addressing the question of liability for infringement arising from the resale of genuine, but altered or diverted goods;
  • Ratification of the initial-interest confusion doctrine;
  • Judicial disapproval of transparently opportunistic claims of priority;
  • Significant opinions from the Trademark Trial and Appeal Board invalidating registrations as fraudulently procured; and
  • Ex parte orders from the Acting Director of the USPTO and the Commissioner for Trademarks sanctioning bad actors.

This webinar will be 60 minutes and will share information on the particulars of law governing trademarks and unfair competition.

Register here by June 20th at 5:00 PM.

About the Speaker:

Ted Davis is a partner in the Atlanta office of Kilpatrick Townsend & Stockton LLP, where he has practiced trademark, copyright, false advertising, and unfair competition law since 1990. Outside the office, he has taught as an adjunct professor at the Emory University and the University of Georgia schools of law and has testified before Congress on trade dress and Internet issues. He is a past member of the International Trademark Association’s Board of Directors, a past chair of the American Bar Association Section of Intellectual Property Law, and a past chair of the American Intellectual Property Law Association’s Trademark Law Committee. As a frequent amicus advocate, he has represented INTA, the ABA, and the AIPLA in a number of briefs submitted to the U.S. Supreme Court.

Ted received his undergraduate degree from Davidson College and his law degree from the University of Virginia. He is a member of the Georgia, New York, and District of Columbia bars.

Share

Recent Developments in Pharmaceutical Patent Law

Jeremy Cobb, Arnold & Porter

Join us on May 24, 2022 for our next webinar. We anticipate 1.00 General CLE credit in Ohio for this event. 

Our presenter will be Jeremy Cobb from Arnold & Porter. Mr. Cobb will present on Recent Developments in Pharmaceutical Patent Law-Biotherapeutics, Enablement, and Written Description. 

Since the approval of the first antibody therapy in 1986, the focus of drug discovery and development has gradually shifted away from small, well-defined chemical molecules to large, complex therapeutic biologics. Biotherapeutics are now playing an increasingly prominent role in combating diseases like cancer and autoimmune diseases. Recently, the Federal Circuit has issued key opinions that provide guidance as to which patent claims can withstand 35 U.S.C. § 112 enablement or written description challenges. This presentation will provide an analysis of recent Federal Circuit opinions and their implications for biotherapeutic patents going forward.

This webinar will be 60 minutes and will share information on the particulars of law governing patents directed toward pharmaceutical inventions.

Register here by May 20th at 5:00 PM.

About the Speaker:

Jeremy Cobb focuses on patent litigation and matters before the Patent Trial and Appeal Board with an emphasis on small molecule and biological patents. He is a senior associate focused on matters from case inception through trial and appeal. His experience includes arguing motions and claim construction, taking and defending expert and fact depositions, and overseeing case strategy and management. Mr. Cobb also has a deep understanding of pharmaceutical patent practice, including Hatch-Waxman litigation; regulatory exclusivity; patent term extensions; and pharmaceutical life cycle management.

Prior to becoming an attorney, Mr. Cobb designed and developed synthetic routes to active pharmaceutical ingredients and their intermediates at GlaxoSmithKline.

Share

Data in the Cloud – Feet on the Ground

Daniel McMullen, Calfee, Halter & Griswold LLP
Ashley Earle, Calfee, Halter & Griswold LLP

Join us on March 29, 2022 for our next webinar. We anticipate 1.00 General CLE credit in Ohio for this event. 

Mr. McMullen and Ms. Earle will discuss how to stay afloat in the ever-changing legal landscape affecting data rights and privacy, touching on multiple topics, including an overview and update on recent state data privacy legislation; guidance on issue-spotting under data-specific regulations (such as HIPAA, GLBA, FERPA and FCRA); data breach response and reporting requirements (including the Ohio Data Protection Act ‘safe harbor’); best practices in contracting around data rights, privacy and confidentiality; and practical considerations for drafting and operating under privacy policies.

This webinar will be 60 minutes and will share information on how data rights and privacy are evolving in the modern world.

Register here by March 25th at 5:00 PM.

About the Speakers:

Daniel McMullen is a Partner that leads Calfee’s Information Technology practice. He provides skilled counsel to address clients’ legal needs regarding computer software and content development, licensing, cloud computing and SaaS subscriptions, hosting and service level agreements, outsourcing, data rights, privacy, cybersecurity, blockchain and other online/Internet, website and e-commerce matters. 

Mr. McMullen also handles intellectual property matters across traditional business, new media and entertainment sectors. He represents public and closely held business clients in all forms of intellectual property negotiations, and occasionally, dispute resolution, including patent, copyright and trademark infringement actions, as well as complex computer system litigation.

Ashley Earle is an Associate with Calfee’s Intellectual Property practice group. Her practice centers around branding protection, as well as data privacy and agreement consultation and review.

With a broad range of experience in intellectual property law – including trademark, copyright, trade secret, design patent, utility patent, privacy, and licensing matters – Ms. Earle works to help clients protect their innovations and creations by securing and enforcing trademarks, copyrights, and patents, both domestically and abroad. She counsels clients from the fruition of an idea through to execution, implementation, protection, monetization, and enforcement. Ms. Earle’s practice focuses on branding protection to create and enforce brands and their related intellectual property on a global scale. She manages large, international portfolios and provides strategic client counseling to determine the best path forward for each client based on their needs and goals in the relevant market.

Ms. Earle is well-versed in data privacy and security. She is a Certified Information Privacy Professional (CIPP-US certification through the International Association of Privacy Professionals) and is in the process of completing her CIPP certification for the European Union.

Share